New CEPI-funded trial to launch in Kenya – the first ever Phase II trial of a Rift Valley fever vaccine in an endemic country Earlier vaccine studies show positive safety data, and generation of an immune response Rift Valley fever is a mosquito-borne disease affecting people and animals across Africa OSLO/NAIROBI, October 13 – A […]

The fight against sickle cell disease (SCD) has seen significant progress thanks to the ongoing research conducted by KEMRI-Wellcome Trust Research Programme (KWTRP) in collaboration with Kilifi County Teaching and Referral Hospital (KCTRH) through the joint management of the pediatric sickle cell clinic. The clinic which also serves neighbouring counties provides diagnosis (for children) and […]

In our 2023 Annual Report, we highlight our progress in science, capacity development, & impact. We also celebrate our people, highlighting individual & collective achievements.

The KEMRI Wellcome Trust Research Programme (KWTRP) hosted its annual policy engagement forum at the Radisson Blu Hotel in Nairobi. This year’s forum provided a valuable platform for deliberation between policy stakeholders and researchers, focusing on their research needs and policy priorities. The event is part of a larger consultative process towards the development of […]

A huge congratulations to our researchers Martha Mwangome, Charles Sande and Marta Maia who were among six researchers who have been awarded the title Associate Professor by Oxford University. Martha Mwangome, working in the Nutrition assessment and Intervention research group at the KEMRI Wellcome Trust Research Programme (KWTRP) in Kilifi, Kenya. Charles Sande, researcher on […]

Serosurveillance remains a valuable yet underutilized tool. Through the KEMIS project, we aim to demonstrate the value of multi-pathogen serosurveillance in Kenya. Since 2021, we have conducted serosurveys among populations residing within health and demographic surveillance sites in Kilifi, Nairobi, Kisumu and Siaya. Samples collected during the surveys are tested for IgG antibodies using cutting […]